Journal of Peking University (Health Sciences) ›› 2021, Vol. 53 ›› Issue (6): 1139-1143. doi: 10.19723/j.issn.1671-167X.2021.06.022

Previous Articles     Next Articles

Preoperative plasma predictive factors of new-onset atrial fibrillation after coronary artery bypass graft surgery: A propensity score matching study

XU Hao,ZHANG Guo-dong,FAN Guang-pu,CHEN Yu()   

  1. Department of Cardiac Surgery, Heart Center, Peking University People’s Hospital, Beijing 100044, China
  • Received:2019-12-02 Online:2021-12-18 Published:2021-12-13
  • Contact: Yu CHEN E-mail:chenyu@pkuph.edu.cn

Abstract:

Objective: To study the relationship between preoperative plasma interleukin-1 (IL-1), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), homocysteine (Hcy), endothelin-1 (ET-1) levels and new-onset atrial fibrillation (AF) after coronary artery bypass grafting (CABG). Methods: In the study, 148 patients who underwent isolated CABG in Peking University People’s Hospital from January 1, 2017 to December 30, 2017 were enrolled, of whom 39 had new-onset AF. The fasting venous blood was collected within 24 hours before the surgery. The preoperative plasma IL-1, IL-6, TNF-α, Hcy, ET-1 levels were detected by enzyme-linked immunosorbent assay (ELISA). The patients were divided into AF group and non-AF group according to whether new-onset AF occurred after operation. After 1 ∶1 propensity score matching (PSM), 38 people were in each group. The paired sample t-tests were performed on the five factors’ concentrations of the matched AF group and the non-AF group respectively. If the concentration values did not conform to the normal distribution, the Wilcoxon signed rank sum test was performed. Conditional Logistic regression analysis was performed on the concentrations of the five indicators to explore the correlation between preoperative plasma concentrations of IL-1, IL-6, TNF-α, Hcy, ET-1 and postoperative new-onset AF after CABG. Results: After a 1 ∶1 propensity score matching, the AF group was comparable to the non-AF group. The concentrations of IL-1, IL-6, TNF-α, and Hcy in the AF group were higher than those in the non-AF group [(0.867±0.589) ng/L vs. (0.742±0.262) ng/L, 21.55 (6.50, 209.90) ng/L vs. 17.95 (3.60, 86.70) ng/L, 20.30 (5.70, 361.00) ng/L vs. 21.50 (7.50, 251.80) ng/L, (0.29±0.11) μmol/L vs. (0.27±0.09) μmol/L], but the differences were not statistically significant (P=0.165, P=0.891, P=0.817, P=0.285). After the conditional Logistic regression analysis, the above four variables were not predictors of new-onset AF after CABG. The concentrations of ET-1 in the matched AF group and non-AF group were (25.80±6.20) ng/L and (29.10±8.54) ng/L, respectively. The correlation between preoperative low plasma ET-1 concentration and the new-onset AF after CABG were statistically significant (P=0.003). After conditional Logistic regression analysis, preoperative plasma ET-1 concentration was correlated with postoperative new-onset AF after CABG (P=0.039, adjusted OR=0.637, 95%CI: 0.415-0.977). Conclusion: The levels of preoperative plasma IL-1, IL-6, TNF-α and Hcy in the patients with new-onset AF after CABG were higher than those in the patients without AF, but the difference was not statistically significant. Preoperative plasma low ET-1 concentration was statistically associated with new-onset AF after CABG.

Key words: Coronary artery disease, Coronary artery bypass, Atrial fibrillation, Risk factors

CLC Number: 

  • R541.75

Table 1

Baseline characteristics of patients before and after propensity score matching"

Items Before matched After matched
AF group (n=39) non-AF group (n=109) P AF group (n=38) non-AF group (n=38) P
Age/years 63.10±8.52 63.50±9.52 0.800 62.68±8.61 62.86±10.99 0.363
Male 27 (69.2) 80 (73.4) 0.618 27 (71.1) 29 (76.3) 0.602
Body mass index/(kg/m2) 26.79±4.44 25.10±4.16 0.034 26.03±4.54 25.75±5.32 0.816
Smoking 21 (53.8) 49 (45.0) 0.340 18 (47.4) 17 (44.7) 0.818
Diabetes mellitus 18 (46.2) 31 (28.4) 0.044 16 (42.1) 11 (28.9) 0.231
Hypertension 27 (69.2) 63 (57.8) 0.209 27 (71.1) 25 (65.8) 0.622
Hyperlipidemia 4 (10.3) 10 (9.2) 0.843 4 (10.5) 5 (13.2) >0.999
Left atrium diameter/mm 38.00±5.48 38.21±5.19 0.812 38.79±6.00 38.04±4.19 0.530
LVEF/% 60.75±14.33 61.04±12.84 0.910 61.20±8.99 62.21±11.21 0.725
NYHA class 0.332 0.602
0 (0) 1 (0.9) 0 (0) 0 (0)
30 (76.9) 91 (83.5) 27 (71.1) 29 (76.3)
9 (23.1) 15 (13.8) 11 (28.9) 9 (23.7)
0 (0) 2 (1.8) 0 (0) 0 (0)
Prior cardiac surgery/PCI 6 (15.4) 16 (14.7) 0.915 6 (15.8) 8 (21.1) 0.554
Preoperative laboratory parameters
Creatinine/(μmol/L) 69.0 (46.0, 214.0) 69.5 (38.0, 173.0) 0.029 72.0 (46.0, 214.0) 66.5 (42.0, 173.0) 0.939
Total cholesterol/(mmol/L) 4.05±1.45 3.85±1.17 0.379 4.05±1.46 4.00±1.00 0.872
LDL/(mmol/L) 2.18 (1.17, 6.00) 2.40 (0.64, 6.51) 0.237 2.45 (1.00, 6.00) 2.09 (1.00, 4.00) 0.858
Blood glucose/(mmol/L) 6.22 (4.23, 13.20) 5.48 (3.79, 14.71) 0.337 5.76 (4.00, 11.00) 5.50 (4.00, 13.00) 0.534
Cardiopulmonary bypass 0.935 0.798
On-pump 11 (28.2) 30 (27.5) 11 (28.9) 10 (26.3)
Off-pump 28 (71.8) 79 (72.5) 27 (71.1) 28 (73.7)
IABP 3 (7.7) 5 (4.6) 0.746 1 (2.6) 3 (7.9) 0.607
Blood transfusion 20 (51.3) 50 (45.9) 0.561 17 (44.7) 19 (50.0) 0.646
Ventilation time 13 (5, 283) 12 (3, 253) 0.794 12 (5, 250) 10 (5, 222) 0.392
Re-intubation 1 (2.6) 1 (0.9) 0.459 0 (0) 0 (0) >0.999
ICU time/h 23 (7, 293) 20 (6, 288) 0.088 21 (7, 271) 23 (8, 263) 0.564
Preoperative medication
Nitroglycerin 35 (89.7) 98 (89.9) >0.999 35 (92.1) 34 (89.5) >0.999
Catecholamine 0 (0) 0 (0) >0.999 0 (0) 0 (0) >0.999
Beta-blocker 36 (92.3) 103 (94.5) 0.920 36 (94.7) 35 (92.1) >0.999
ACEI/ARB 8 (20.5) 17 (15.6) 0.482 8 (21.1) 8 (21.1) >0.999
Statin 37 (94.9) 109 (100.0) 0.116 37 (97.4) 38 (100.0) >0.999
Asprin 37 (94.9) 98 (89.9) 0.542 36 (94.7) 33 (86.8) 0.428
Clopidogrel 4 (10.3) 10 (9.2) >0.999 2 (5.3) 4 (10.5) 0.671
Ticagrelor 0 (0) 0 (0) >0.999 0 (0) 0 (0) >0.999
Postoperative medication
Catecholamine 37 (94.9) 105 (96.3) >0.999 36 (94.7) 36 (94.7) >0.999
Nitroglycerin 37 (94.9) 104 (95.4) >0.999 36 (94.7) 38 (100.0) 0.474
Beta-blocker 38 (25.6) 109 (100.0) 0.590 37 (97.4) 38 (100.0) >0.999
ACEI/ARB 10 (7.7) 16 (14.7) 0.194 8 (21.1) 8 (21.1) >0.999
Statin 38 (97.4) 106 (97.2) >0.999 37 (97.4) 36 (94.7) >0.999
Asprin 38 (97.4) 107 (98.2) >0.999 37 (97.4) 38 (100.0) >0.999
Clopidogrel 9 (23.1) 24 (22.0) 0.892 6 (15.8) 6 (15.8) >0.999
Ticagrelor 0 (0) 0 (0) >0.999 0 (0) 0 (0) >0.999

Table 2

Preoperative plasma levels of factors"

Items AF group non-AF group P
IL-1/(ng/L) 0.867±0.589 0.742±0.262 0.165
IL-6/(ng/L) 21.55 (6.50, 209.90) 17.95 (3.60, 86.70) 0.891
TNF-α/(ng/L) 20.30 (5.70, 361.00) 21.50 (7.50, 251.80) 0.817
Hcy/(μmol/L) 0.29±0.11 0.27±0.09 0.285
ET-1/(ng/L) 25.80±6.20 29.10±8.54 0.003

Table 3

Conditional Logistic regression analysis results"

Items P Adjusted OR 95%CI
IL-1 0.573 2.131 0.153-29.612
IL-6 0.366 0.978 0.933-1.026
TNF-α 0.131 1.026 0.992-1.061
Hcy 0.413 4.333 0.111-168.320
ET-1 0.039 0.637 0.415-0.977
[1] El-Chami MF, Kilgo P, Thourani V, et al. New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft[J]. J Am Coll Cardiol, 2010, 55(13):1370-1376.
doi: 10.1016/j.jacc.2009.10.058 pmid: 20338499
[2] 孙源君. 心房颤动与肺栓塞的关系及治疗[J]. 中国循环杂志, 2018, 33(3):307-309.
[3] Hak L, Mysliwska J, Wieckiewicz J, et al. Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG)[J]. J Interferon Cytokine Res, 2009, 29(6):327-332.
doi: 10.1089/jir.2008.0082.2906
[4] Wu ZK, Laurikka J, Vikman S, et al. High postoperative interleukin-8 levels related to atrial fibrillation in patients undergoing coronary artery bypass surgery[J]. World J Surg, 2008, 32(12):2643-2649.
doi: 10.1007/s00268-008-9758-7
[5] 王淑娟, 林祥灿. 血浆NT-proBNP水平与同型半胱氨酸对糖尿病合并心房颤动的相关性研究[J]. 医学信息, 2018, 31(14):169-171.
[6] 刘明, 魏兰芳, 薛洋, 等. 血清同型半胱氨酸与心房颤动的关系[J]. 中国循证心血管医学杂志, 2017, 9(1):117-118.
[7] Wang H, Liu J, Fang P, et al. Big endothelin-1 as a predictor of atrial fibrillation recurrence after primary ablation only in patients with paroxysmal atrial fibrillation[J]. Herz, 2012, 37(8):919-925.
doi: 10.1007/s00059-012-3626-9 pmid: 22669310
[8] 徐颖. 高敏C反应蛋白、脑钠肽、内皮素1与非瓣膜性心房颤动关系的探讨[D]. 天津: 天津医科大学, 2011.
[9] 洪钰杰, 钟国强, 蒋智渊, 等. 内皮素-1在心房颤动发生中的机制探讨[J]. 中国循环杂志, 2016, 31(2):146-150.
[10] 郭瑾. 焦虑抑郁患者血清NO、ET-1、vWF表达水平研究[D]. 太原: 山西医科大学, 2018.
[11] 邓晓雯. KL-6、ET-1在OSAHS患者中的血清水平及其意义[D]. 湖南衡阳: 南华大学, 2014.
[12] 马朝晖, 张仁福, 姜辉, 等. 三种心脏停搏液对心肌保护的对比研究[J]. 中国循环杂志, 2000, 15(1):40-42.
[1] SU Jun-qi,SONG Yang,XIE Shang. Analysis of etiological characteristics and establishment of prediction model of postoperative infections in patients undergoing oral squamous cell carcinoma surgery with free flap reconstruction [J]. Journal of Peking University (Health Sciences), 2022, 54(1): 68-76.
[2] NIU Zhan-yue,XUE Yan,ZHANG Jing,ZHANG He-jun,DING Shi-gang. Analysis of endoscopic and pathological features of gastric adenomatous polyps and risk factors for canceration [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1122-1127.
[3] Jing-xian ZHU,Sheng-nan LU,Yan-fang JIANG,Ling JIANG,Jian-quan WANG. Influencing factors of preoperative pulmonary function in elderly patients undergoing rotator cuff surgery [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 902-906.
[4] WANG Jia-wen,LIU Jing-chao,MENG Ling-feng,ZHANG Wei,LIU Xiao-dong,ZHANG Yao-guang. Quality of life and related factors in patients with interstitial cystitis/bladder pain syndrome [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 653-658.
[5] SUN Zheng-hui,HUANG Xiao-juan,DONG Jing-han,LIU Zhuo,YAN Ye,LIU Cheng,MA Lu-lin. Risk factors of renal sinus invasion in clinical T1 renal cell carcinoma patients undergoing nephrectomy [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 659-664.
[6] ZHOU Bo-lin,LI Wei-shi,SUN Chui-guo,QI Qiang,CHEN Zhong-qiang,ZENG Yan. Risk factors for multiple debridements of the patients with deep incisional surgical site infection after spinal surgery [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 286-292.
[7] XIA Fang-fang,LU Fu-ai,LV Hui-min,YANG Guo-an,LIU Yuan. Clinical characteristics and related factors of systemic lupus erythematosus with interstitial pneumonia [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 266-272.
[8] YANG Yang,XIAO Feng,WANG Jin,SONG Bo,LI Xi-hui,ZHANG Shi-jie,HE Zhi-song,ZHANG Huan,YIN Ling. One-stage surgery in patients with both cardiac and non-cardiac diseases [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 327-331.
[9] LIU Xiao-qiang,YANG Yang,ZHOU Jian-feng,LIU Jian-zhang,TAN Jian-guo. Blood pressure and heart rate changes of 640 single dental implant surgeries [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 390-395.
[10] HOU Guo-jin,ZHOU Fang,TIAN Yun,JI Hong-quan,ZHANG Zhi-shan,GUO Yan,LV Yang,YANG Zhong-wei,ZHANG Ya-wen. Risk factors of recurrent kyphosis in thoracolumbar burst fracture patients treated by short segmental pedicle screw fixation [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 167-174.
[11] MENG Zhao-ting,MU Dong-liang. Impact of oliguria during lung surgery on postoperative acute kidney injury [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 188-194.
[12] WANG Ying-chun,HUANG Yong-hui,CHANG Hong,YAO Wei,YAN Xiu-e,LI Ke,ZHANG Yao-peng,ZHENG Wei. Characteristics of benign and malignant lesions of ampullary polyps and the accuracy of forceps biopsy [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 204-209.
[13] Jia-li CHEN,Yue-bo JIN,Yi-fan WANG,Xiao-ying ZHANG,Jing LI,Hai-hong YAO,Jing HE,Chun LI. Clinical characteristics and risk factors of cardiovascular disease in patients with elderly-onset rheumatoid arthritis: A large cross-sectional clinical study [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1040-1047.
[14] Teng-fei LIU,Tao LIN,Li-hui REN,Guang-ping LI,Jian-jun PENG. Association between CMTM5 gene and coronary artery disease and the relative mechanism [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1082-1087.
[15] Yi-fan WANG,Zhen FAN,Yao-bin CHENG,Yue-bo JIN,Yang HUO,Jing HE. Investigation of sleep disturbance and related factors in patients with primary Sjögren’s syndrome [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1063-1068.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 376 -379 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 459 -462 .
[5] . [J]. Journal of Peking University(Health Sciences), 2010, 42(1): 82 -84 .
[6] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 319 -322 .
[7] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 333 -336 .
[8] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 337 -340 .
[9] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[10] . [J]. Journal of Peking University(Health Sciences), 2007, 39(4): 346 -350 .